PharmGen Science, Inc.
004720 | KO
Overview
Corporate Details
- ISIN(s):
- KR7004720009
- LEI:
- Country:
- South Korea
- Address:
- 경기 화성시 향남면 상신리 향남제약공단 902-5, 화성시
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
No description available.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
You have of free filing views remaining.
Upgrade for unlimited access.
Bulk Actions:
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-08-19 00:00 |
Interim / Quarterly Report
[기재정정]반기보고서 (2025.06)
|
Korean | 1.4 MB | ||
| 2025-08-14 00:00 |
Interim / Quarterly Report
반기보고서 (2025.06)
|
Korean | 1.4 MB | ||
| 2025-08-12 00:00 |
Share Issue/Capital Change
전환청구권ㆍ신주인수권ㆍ교환청구권행사
|
Korean | 15.9 KB | ||
| 2025-06-12 00:00 |
Share Issue/Capital Change
전환청구권ㆍ신주인수권ㆍ교환청구권행사
|
Korean | 14.0 KB | ||
| 2025-05-15 00:00 |
Quarterly Report
분기보고서 (2025.03)
|
Korean | 1.8 MB | ||
| 2025-04-14 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 24.2 KB | ||
| 2025-04-14 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 25.9 KB | ||
| 2025-04-14 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 25.9 KB | ||
| 2025-04-14 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 26.0 KB | ||
| 2025-04-14 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
|
Korean | 110.0 KB | ||
| 2025-04-11 00:00 |
Share Issue/Capital Change
전환가액ㆍ신주인수권행사가액ㆍ교환가액의조정(안내공시)
|
Korean | 14.4 KB | ||
| 2025-04-10 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
|
Korean | 677.5 KB | ||
| 2025-04-03 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 24.1 KB | ||
| 2025-04-03 00:00 |
Major Shareholding Notification
[기재정정]임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 34.9 KB | ||
| 2025-03-31 00:00 |
AGM Information
정기주주총회결과
|
Korean | 28.6 KB |
Automate Your Workflow. Get a real-time feed of all PharmGen Science, Inc. filings delivered via API.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
Unlock Full Financials for PharmGen Science, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for PharmGen Science, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
Company
Country
Ticker
View
Develops T-cell and antibody immunotherapies for cancer and autoimmune diseases.
South Korea
263050
South Korea
263050
Develops and commercializes a nasal spray for diabetic gastroparesis symptom relief.
United States of America
EVOK
United States of America
EVOK
Develops neurotoxins and dermal fillers for the medical aesthetics market.
United States of America
EOLS
United States of America
EOLS
Biopharma firm using ultrasound to enhance drug delivery for oncology via its ACT® platform.
Norway
EXTX
Norway
EXTX
An oncology-focused biotech that discovers and develops medicines for hard-to-treat cancers.
United States of America
EXEL
United States of America
EXEL
Clinical-stage biotech developing vaccines and immunotherapies via a proprietary protein platform.
Sweden
EXPRS2
Sweden
EXPRS2
Develops innovative, sustained-delivery therapeutics for retinal diseases.
United States of America
EYPT
United States of America
EYPT
Develops and markets pharmaceuticals, like antihistamines, and animal nutrition products globally.
Spain
FAE
Spain
FAE
Supplies compounding ingredients and solutions for personalized medicine to healthcare professionals.
Belgium
FAGR
Belgium
FAGR
A pharmaceutical manufacturer and exporter of 400+ medicines to over 50 countries.
Ukraine
FARM
Ukraine
FARM